T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
XP
XP
$8.19B
| $423M | 0.04% |
14,710,663
-6,556,651
| -31% | -$214M |
|
377
BWX Technologies
BWXT
$15.6B
| $421M | 0.04% |
8,801,382
-545,262
| -6% | -$28.5M |
|
378
Baxter International
BAX
$14B
| $421M | 0.04% |
4,899,602
-491,001
| -9% | -$39.5M |
|
379
Northern Trust
NTRS
$34.8B
| $420M | 0.04% |
3,508,171
-9,676
| -0.3% | -$1.16M |
|
380
Insmed
INSM
$27.8B
| $417M | 0.04% |
15,321,204
+580,772
| +4% | +$16.6M |
|
381
Perrigo
PRGO
$1.74B
| $417M | 0.04% |
10,721,574
-8,494,362
| -44% | -$357M |
|
|
ACC
382
DELISTED
American Campus Communities, Inc.
ACC
| $417M | 0.04% |
7,277,366
-248,150
| -3% | -$13.2M |
|
383
Magnolia Oil & Gas
MGY
$6.12B
| $416M | 0.04% |
22,059,427
+1,699,642
| +8% | +$33.7M |
|
384
Jacobs Solutions
J
$16.8B
| $413M | 0.04% |
3,588,639
-2,020,310
| -36% | -$234M |
|
385
Northrop Grumman
NOC
$81.6B
| $412M | 0.04% |
1,063,588
-169,080
| -14% | -$63M |
|
386
Corteva
CTVA
$50.2B
| $408M | 0.04% |
8,637,652
-62,317
| -0.7% | -$2.84M |
|
387
Kemper
KMPR
$1.57B
| $407M | 0.04% |
6,917,868
+936,959
| +16% | +$57M |
|
388
Freeport-McMoran
FCX
$94.2B
| $405M | 0.04% |
9,698,079
-97,402
| -1% | -$3.7M |
|
389
Brown & Brown
BRO
$23.7B
| $403M | 0.04% |
5,739,831
-88,021
| -2% | -$5.68M |
|
390
United Rentals
URI
$70.2B
| $402M | 0.04% |
1,210,836
-52,242
| -4% | -$18.6M |
|
391
Automatic Data Processing
ADP
$108B
| $401M | 0.04% |
1,626,683
-29,247
| -2% | -$6.62M |
|
|
AVLR
392
DELISTED
Avalara, Inc.
AVLR
| $400M | 0.04% |
3,101,083
-2,180,505
| -41% | -$340M |
|
393
BioNTech
BNTX
$23.2B
| $396M | 0.04% |
1,537,723
+373,884
| +32% | +$102M |
|
394
Sysco
SYY
$40.3B
| $395M | 0.04% |
5,033,991
-95,403
| -2% | -$7.34M |
|
395
Regency Centers
REG
$14.1B
| $391M | 0.04% |
5,194,647
-467,323
| -8% | -$33.7M |
|
396
Micron Technology
MU
$1.09T
| $388M | 0.03% |
4,168,430
-3,026,446
| -42% | -$236M |
|
|
ZNGA
397
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $387M | 0.03% |
60,541,952
-1,405,641
| -2% | -$9.7M |
|
398
FIGS
FIGS
$2.44B
| $387M | 0.03% |
14,057,521
+1,040,342
| +8% | +$34.3M |
|
|
THS
399
DELISTED
Treehouse Foods
THS
| $385M | 0.03% |
9,499,610
-81,548
| -0.9% | -$3.15M |
|
400
Ionis Pharmaceuticals
IONS
$9.26B
| $380M | 0.03% |
12,490,280
+752,959
| +6% | +$23.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.